(ANSA) - ROME, MARCH 11 - The temporary suspension of the use of the AstraZeneca vaccine in Denmark is linked to "reports of serious cases of blood clots among vaccinated people", one of whom died. This was reported by the national health authorities. Clarifying that "it has not been determined, at the moment, that there is a link between the vaccine and blood clots". However, Lapremier Mette Frederiksen explained that "further research needs to be done on this point". Discontinuation of use of AstraZeneca is scheduled for two weeks. A new evaluation will take place on 22 March. (HANDLE).
Denmark, AstraZeneca suspension also due to suspicious death
2021-03-11T15:14:00.892Z
The temporary suspension of the use of the AstraZeneca vaccine in Denmark is linked to "reports of serious cases of blood clots among vaccinated people", one of which has died. The national health authorities reported this. (HANDLE)